Ovarian and Adipose Tissue Dysfunction in Polycystic Ovary Syndrome: Report of the 4th Special Scientific Meeting of the Androgen Excess and PCOS Society

Overview

Journal Fertil Steril

Specialty Reproductive Medicine

Date 2009 Apr 28

PMID 19394000

Citations 6

Authors

Bulent O Yildiz

Ricardo Azziz

Affiliations

Soon will be listed here.

Abstract

Significant advances have been made in our understanding of ovarian dysfunction in polycystic ovary syndrome (PCOS), and alterations in adipose tissue function are likely to play an important role in its pathophysiology. This review highlights the principal novel concepts presented at the 4th special scientific meeting of the Androgen Excess and PCOS Society, "Ovarian and Adipose Tissue Dysfunction: Potential Roles in Polycystic Ovary Syndrome," which occurred on June 6, 2008 in San Francisco, California.

Citing Articles

Influence of Maternal Diet and Intergenerational Change in Diet Type on Ovarian and Adipose Tissue Morphology in Female Rat Offspring.

cekic N, Grgic A, Kokot A, Mujkic R, Snajder Mujkic D, Bijelic N Medicina (Kaunas). 2022; 58(7).

PMID: 35888573 PMC: 9318591. DOI: 10.3390/medicina58070854.

Irisin reduces the abnormal reproductive and metabolic phenotypes of PCOS by regulating the activity of brown adipose tissue in mice†.

Zheng Y, He J, Yang D, Yuan M, Liu S, Dai F Biol Reprod. 2022; 107(4):1046-1058.

PMID: 35713297 PMC: 9562123. DOI: 10.1093/biolre/ioac125.

The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy.

Spinedi E, Cardinali D Int J Endocrinol. 2018; 2018:1349868.

PMID: 30147722 PMC: 6083563. DOI: 10.1155/2018/1349868.

Gene expression in subcutaneous adipose tissue differs in women with polycystic ovary syndrome and controls matched pair-wise for age, body weight, and body mass index.

Manneras-Holm L, Benrick A, Stener-Victorin E Adipocyte. 2014; 3(3):190-6.

PMID: 25068085 PMC: 4110095. DOI: 10.4161/adip.28731.

State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).

Geller D, Pacaud D, Gordon C, Misra M Int J Pediatr Endocrinol. 2011; 2011:9.

PMID: 21899727 PMC: 3180691. DOI: 10.1186/1687-9856-2011-9.

References

Sverrisdottir Y, Mogren T, Kataoka J, Janson P, Stener-Victorin E . Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?. Am J Physiol Endocrinol Metab. 2008; 294(3):E576-81. DOI: 10.1152/ajpendo.00725.2007. View

Magoffin D . Ovarian enzyme activities in women with polycystic ovary syndrome. Fertil Steril. 2006; 86 Suppl 1:S9-S11. DOI: 10.1016/j.fertnstert.2006.03.015. View

Ciaraldi T . Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity. J Pediatr Endocrinol Metab. 2000; 13 Suppl 5:1291-3. View

Chang W, Goodarzi M, Williams H, Magoffin D, Pall M, Azziz R . Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3. Fertil Steril. 2008; 90(6):2291-7. PMC: 2744855. DOI: 10.1016/j.fertnstert.2007.10.025. View

Manneras L, Jonsdottir I, Holmang A, Lonn M, Stener-Victorin E . Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome. Endocrinology. 2008; 149(7):3559-68. DOI: 10.1210/en.2008-0053. View

Franks S, Stark J, Hardy K . Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008; 14(4):367-78. DOI: 10.1093/humupd/dmn015. View

Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Orio F . Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab. 2007; 92(7):2500-5. DOI: 10.1210/jc.2006-2725. View

Corton M, Botella-Carretero J, Benguria A, Villuendas G, Zaballos A, San Millan J . Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006; 92(1):328-37. DOI: 10.1210/jc.2006-1665. View

Escobar-Morreale H, San Millan J . Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab. 2007; 18(7):266-72. DOI: 10.1016/j.tem.2007.07.003. View

10.

Wickenheisser J, Nelson-Degrave V, McAllister J . Human ovarian theca cells in culture. Trends Endocrinol Metab. 2006; 17(2):65-71. DOI: 10.1016/j.tem.2006.01.003. View

11.

Corbould A . Effects of spironolactone on glucose transport and interleukin-6 secretion in adipose cells of women. Horm Metab Res. 2007; 39(12):915-8. DOI: 10.1055/s-2007-993156. View

12.

Abbott D, Zhou R, Bird I, Dumesic D, Conley A . Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome. Endocr Dev. 2008; 13:145-158. PMC: 2531212. DOI: 10.1159/000134831. View

13.

Carmina E, Bucchieri S, Mansueto P, Rini G, Ferin M, Lobo R . Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertil Steril. 2008; 91(4 Suppl):1332-5. DOI: 10.1016/j.fertnstert.2008.03.007. View

14.

Chang R . The reproductive phenotype in polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab. 2007; 3(10):688-95. DOI: 10.1038/ncpendmet0637. View

15.

Ciaraldi T, Aroda V, Mudaliar S, Chang R, Henry R . Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance. J Clin Endocrinol Metab. 2008; 94(1):157-63. PMC: 2630871. DOI: 10.1210/jc.2008-1492. View

16.

Blouin K, Veilleux A, Luu-The V, Tchernof A . Androgen metabolism in adipose tissue: recent advances. Mol Cell Endocrinol. 2008; 301(1-2):97-103. DOI: 10.1016/j.mce.2008.10.035. View

17.

Arner P . Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome. Biochimie. 2005; 87(1):39-43. DOI: 10.1016/j.biochi.2004.11.012. View

18.

Corton M, Botella-Carretero J, Lopez J, Camafeita E, San Millan J, Escobar-Morreale H . Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum Reprod. 2007; 23(3):651-61. DOI: 10.1093/humrep/dem380. View

19.

Abbott D, Barnett D, Levine J, Padmanabhan V, Dumesic D, Jacoris S . Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys. Biol Reprod. 2008; 79(1):154-63. PMC: 2531213. DOI: 10.1095/biolreprod.108.067702. View

20.

Tan B, Heutling D, Chen J, Farhatullah S, Adya R, Keay S . Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes. 2008; 57(6):1501-7. DOI: 10.2337/db08-0127. View